Atlas Lithium Corporation (ATLX) Stock Forecast
Data as of May 9, 2026Basic Materials · Current price $6.29 (+6.25%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
ATLX vs Sector & Market
| Metric | ATLX | Basic Materials Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.36 | 2.41 |
| Analyst Count | 2 | 7 | 19 |
| Target Upside | +202.1% | +67.6% | +16.4% |
| P/E Ratio | -4.42 | -11.88 | 27.60 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $54M | $54M | $54M | 1 |
| 2027-12-31 | $218M | $218M | $218M | 1 |
| 2028-12-31 | $218M | $218M | $218M | 1 |
| 2029-12-31 | $218M | $218M | $218M | 1 |
| 2030-12-31 | $381M | $381M | $381M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-0.23 | $-0.23 | $-0.23 | 1 |
| 2027-12-31 | $0.00 | $0.00 | $0.00 | 0 |
| 2028-12-31 | $0.00 | $0.00 | $0.00 | 0 |
| 2029-12-31 | $0.00 | $0.00 | $0.00 | 0 |
| 2030-12-31 | $0.00 | $0.00 | $0.00 | 0 |
Frequently Asked Questions
What is the analyst consensus for ATLX?
The consensus among 2 analysts covering Atlas Lithium Corporation (ATLX) is Buy with an average price target of $19.00.
What is the highest price target for ATLX?
The highest analyst price target for ATLX is $19.00.
What is the lowest price target for ATLX?
The lowest analyst price target for ATLX is $19.00.
How many analysts cover ATLX?
2 analysts have issued ratings for Atlas Lithium Corporation in the past 12 months.
Is ATLX a buy or sell right now?
Based on 2 analyst ratings, ATLX has a consensus rating of Buy (2.00/5) with a +202.1% upside to the consensus target of $19.00.
What are the earnings estimates for ATLX?
Analysts estimate ATLX will report EPS of $-0.23 for the period ending 2026-12-31, with revenue estimated at $54M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.